findmyKOL
Clinical trialNCT00136435CompletedPhase 2Interventional

A Study in Adults With Untreated Acute Lymphoblastic Leukemia

SponsorDana-Farber Cancer InstituteEnrollment100Acute Lymphoblastic Leukemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Manitoba Blood & Marrow Transplant Program Cancercare Manitoba

    Winnipeg, Manitoba, Canada

  • Mcmaster University Medical Center

    Hamilton, Ontario, Canada

  • Queen'S University

    Kingston, Ontario, Canada

  • London Health Sciences Centre

    London, Ontario, Canada

  • Sunnybrook Health Sciences Centre

    Toronto, Ontario, Canada

  • Hospital Maisonneuve-Rosemont

    Montreal, Quebec, Canada

  • Royal Victoria Hospital

    Montreal, Quebec, Canada

  • Saskatoon Cancer Centre

    Saskatoon, Saskatchewan, Canada

  • Queen Elizabeth Ii

    Halifax, Canada

United States
  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • University of Columbia Medical Center

    New York, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2002
Primary completion
30 Nov 2008
Completion
31 May 2011
Last update posted
20 Oct 2025
Registered enrollment
100
Registry id
NCT00136435

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.